Effect of the new HJV-L165X mutation on penetrance of HFE [7]

Blood

Volumn 109, Issue 12, 2007, Pages 5525-5526

  Van Dijk, Boukje A C ^a   Kemna, Erwin H J M ^b   Tjalsma, Harold ^b   Klaver, Siem M ^b   Wiegerinck, Erwin T G ^b   Goossens, Jan Pieter ^b   Slee, Peter H Th J ^b   Breuning, Martijn H ^b   Swinkels, Dorine W ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; HEMOJUVELIN; HEPCIDIN; MESSENGER RNA; TRANSFERRIN;

ALLELE; BLOOD SAMPLING; ENDOPLASMIC RETICULUM; EXON; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; INFORMED CONSENT; INSTITUTIONAL REVIEW; LETTER; LIVER CELL; NUCLEOTIDE SEQUENCE; PENETRANCE; PHLEBOTOMY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; STOP CODON; URINALYSIS; WILD TYPE;

EID: 34249990089     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-11-058560     Document Type: Letter

References (12)

1. Goossens JP. Idiopathic haemochromatosis: Juvenile and familial type - endocrine aspects. Neth J Med. 1975;18:161-169.
2. Goossens JP, van Eijk HG, Frenkel M, Wilson JH. Iron stores in familial haemochromatosis. Neth J Med. 1976;19:279-286.
3. Goossens JP, Schreuder I, Went LN. Inheritance of idiopathic haemochromatosis. Lancet. 1977;1:1106-1107.
4. Kemna EHJM, Tjalsma H, Podust VN, Swinkels DW. Mass spectometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007;53:620-628.
5. Lee PL, Beutler E, Rao SV, Barton JC. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood. 2004;103:4669-4671.
6. Silvestri L, Pagani A, Fazi C, et al. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood. 2007. Prepublished on January 30, 2007, as doi: 10.1182/blood-2006-08-041004
7. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38:531-539.
8. De Gobbi M, Roetto A, Piperno A, et al. Natural history of juvenile haemochromatosis. Br J Haematol. 2002;117:973-979.
9. Biasiotto G, Roetto A, Daraio F, et al. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis. 2004;33:338-343.
10. Le Gac G, Scotet V, Ka C, et al. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet. 2004;13:1913-1918.
11. Wallace DF, Dixon JL, Ramm GA, Anderson GJ, Powell LW, Subramaniam N. Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families. Haematologica. 2005;90:254-255.
12. Anderson GJ, Frazer DM. Iron metabolism meets signal transduction. Nat Genet. 2006;38:503-504.